Clinical trial
Gene Therapy for Alzheimer's Disease Clinical Trial
NCT00017940 · The Shiley Family Trust, Other · Completed
Key facts
| NCT number | NCT00017940 |
|---|---|
| Title | Gene Therapy for Alzheimer's Disease Clinical Trial |
| Official title | A Phase I Study of Ex Vivo Nerve Growth Factor Gene Therapy for Alzheimer's Disease |
| Lead sponsor | The Shiley Family Trust, Other |
| Collaborators | Institute for the Study of Aging (ISOA) University of California, San Diego |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Alzheimer Disease |
| Intervention type | Genetic |
| Interventions | Human Nerve Growth Factor |
| Enrollment | 8 |
| Primary completion | Nov 1, 2003 |
| Completion | Nov 1, 2003 |
| First posted | Jun 22, 2001 |
| Last update posted | Dec 11, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: